Exposure to glucocorticoids in the first part of fetal life is associated with insulin secretory defect in adult human.
We have shown in rodents that high glucocorticoid levels inhibit development of beta-cells during fetal life and lead to insulin deficiency in adulthood. To test whether similar phenomena occur in humans, we compared beta-cell function in adult subjects previously exposed to glucocorticoids during first part of fetal life to non-exposed subjects. The study was conducted in 16 adult participants exposed to glucocorticoids during the first part of fetal life and in 16 non-exposed healthy subjects with normal glucose tolerance matched for age, sex, and BMI. Exposed subjects were descendants from mother at risk of having a child with 21-hydroxylase deficiency that were consequently treated by dexamethasone (1 to 1.5mg/day from the 6th gestational week (GW) to prevent genital virilization. We selected descendant of mother who stopped dexamethasone before the 18th GW following negative genotyping of the fetus. Insulin and glucagon secretion were measured during an oral glucose tolerance test (OGTT), graded intravenous (IV) glucose and arginine test. Insulin sensitivity was measured by hyperinsulinemic-euglycaemic-clamp. Age, BMI and anthropometric characteristics were similar in the 2 groups. Insulinogenic index during OGTT and insulin-sensitivity during the clamp were similar in the 2 groups. In exposed subjects, insulin secretion during graded IV-glucose infusion and after arginine administration decreased by 17% (p=0.02) and 22% (p=0.002) respectively while Glucagon secretion after arginine increased. Over exposure to glucocorticoids during first part of fetal life is associated with lower insulin secretion at adult age, which may lead to abnormal glucose tolerance later in life.